Agilon Health, Inc. (AGL)
85.23
-3.22
(-3.64%)
USD |
NYSE |
Oct 16, 16:00
85.23
0.00 (0.00%)
After-Hours: 18:24
Agilon Health SG&A Expense (TTM) : 259.04M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 259.04M |
| March 31, 2026 | 226.81M |
| December 31, 2025 | 238.54M |
| September 30, 2025 | 238.19M |
| June 30, 2025 | 245.12M |
| March 31, 2025 | 258.45M |
| December 31, 2024 | 268.91M |
| September 30, 2024 | 273.85M |
| June 30, 2024 | 282.79M |
| March 31, 2024 | 292.43M |
| December 31, 2023 | 285.76M |
| September 30, 2023 | 291.29M |
| June 30, 2023 | 271.21M |
| Date | Value |
|---|---|
| March 31, 2023 | 243.88M |
| December 31, 2022 | 213.97M |
| September 30, 2022 | 197.58M |
| June 30, 2022 | 180.28M |
| March 31, 2022 | 171.37M |
| December 31, 2021 | 169.31M |
| September 30, 2021 | 161.56M |
| June 30, 2021 | 157.25M |
| March 31, 2021 | 148.48M |
| December 31, 2020 | 138.31M |
| September 30, 2020 | 92.22M |
| June 30, 2020 | 61.85M |
| March 31, 2020 | 27.60M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Astrana Health, Inc. | 238.52M |
| Starling Oncology, Inc. | 111.45M |
| Nakamoto, Inc. | 24.53M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 93.23M |